Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Chirality develops a proprietary chiral separation technology to produce higher-purity, safer pharmaceutical compounds with less waste than conventional methods like HPLC. It serves scientists and pharmaceutical manufacturers seeking faster, cleaner paths to drug production.
0 investors
0 investors
0 investors
Chitozan Health develops antimicrobial chitosan technology for medical and personal care applications, with a focus on combatting antimicrobial resistance. The company creates chitosan-based products for infection control, medical, and wellness uses.
0 investors
0 investors
0 investors
Chorda Pharma develops a pipeline of opioid-free analgesics for managing chronic pain from conditions such as arthritis, diabetic neuropathy, and sports injuries. Its first product, Capsadyn, is an over-the-counter capsaicin-based topical cream for pain relief.
0 investors
0 investors
Chrysalis Biotherapeutics is a clinical-stage biopharmaceutical company developing peptide therapeutics, led by its drug candidate TP508 (Rusalatide acetate, Chrysalin), which activates endothelial and stem cells to repair tissue after severe viral infection or nuclear radiation. Its immediate target is treating mild to moderate acute respiratory distress syndrome (ARDS) to reduce mortality.
0 investors
0 investors
0 investors
0 investors
0 investors
Cirius Therapeutics is a clinical-stage pharmaceutical company developing therapies for patients with chronic metabolic diseases driven by insulin resistance, including Type 2 Diabetes and obesity.
0 investors
Citius Pharmaceuticals is a late-stage biopharmaceutical company developing and commercializing critical care products, including anti-infectives, oncology and adjunct cancer care treatments, stem cell therapy, and prescription products.
0 investors
CivaTech Oncology develops polymer-encapsulated low dose rate brachytherapy devices—including CivaSheet, CivaString, and CivaDerm—used by radiation oncologists to deliver targeted radiation therapy for solid tumors such as prostate, pancreatic, and skin cancers. The company designs and commercializes FDA-cleared, bioabsorbable radiation therapy products for cancer treatment.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors